speb/financial-data huggingface dataset:
HEALTHX.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 1647056000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 6662000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 6662000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 453000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 453000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 598405000.00
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 216274000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 997777000.00
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 294245000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Other Properties: 99765000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 99765000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 89896000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 89896000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 3946234000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 3946234000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Other Special Charges: 1919414000.00
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Other Special Charges: 17560000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Payables: 641597000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Payables: 641597000.00
HEALTHX.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 18974000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 70932000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 70932000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Pretax Income: -1928610000.00
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Pretax Income: -46346000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
HEALTHX.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 50042000.00
HEALTHX.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -7079757000.00
HEALTHX.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -103566000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 2880000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 2880000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 10174101000.00
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2652955000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 58288000.00
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 13368000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 16290000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 16290000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 3658526000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 3658526000.00
HEALTHX.NS cash_flow (annual, 2025-03-31) — Sale Of Business: 971729000.00
HEALTHX.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 6076660000.00
HEALTHX.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 2853000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 37184000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 85914000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Share Issued: 31810500.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 31810500.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Special Income Charges: -1906291000.00
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 2800000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 6698710000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6698710000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 6336484000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 6336484000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -615209919.17
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 11973900.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Tax Provision: -701220000.00
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -222067000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.36
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 70932000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 70932000.00
HEALTHX.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -44582000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Total Assets: 9743714000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 9743714000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 6698710000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 6698710000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Total Debt: 9190000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 9190000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 8645349000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 8645349000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Total Expenses: 11728098000.00
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 3123695000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 1098365000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1098365000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 3947598000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3947598000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 118169000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 118169000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 758000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 54061000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 54061000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -1692051000.00
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 39913000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -1692051000.00
HEALTHX.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 39913000.00
HEALTHX.NS balance_sheet (annual, 2025-03-31) — Working Capital: 4815920000.00
HEALTHX.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 4815920000.00
HEALTHX.NS income_statement (annual, 2025-03-31) — Write Off: 171597000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 359413000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 2787407000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 31797473.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 7.52
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2575961000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 11683000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 11683000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 31797473.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 7.52
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 239117000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — EBIT: 302726000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — EBITDA: 314409000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 211446000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 860000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 860000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -26804000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Net Income: 239117000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 239117000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 265921000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 239117000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 239117000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 265921000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -860000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -860000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 117534000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 65685090.23
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Operating Income: -147967000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 2787407000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 253818000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 174321000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 301866000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2575961000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 11683000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 23443090.23
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 35945000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.12
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 2935374000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 196875000.00
HEALTHX.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 196875000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 402689000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 3090058000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 724830000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 108030000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 0.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 6588226000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 31815038.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Basic EPS: -3.99
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 51486000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 318105000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 239808000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 240065000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 318105000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 6814946000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 5845000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2849980000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 1657636000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 778996000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 13253000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 13253000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 31815038.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: -3.99
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -126942000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — EBIT: -185993000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — EBITDA: -172740000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 361434000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 367869000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 788663000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 240078000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 1661000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 379000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 379000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 1138291000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 6814946000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 22724000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 6588226000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 51486000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 51486000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 73597000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 1947644000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 27451000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Net Income: -126942000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -126942000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -154393000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -126942000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -126942000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -154393000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -379000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -379000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 788663000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 6447077000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 128915000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 57185000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -94227000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Normalized Income: -61900804.92
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Operating Income: -162611000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 3090058000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 31810500.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 6496841000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 6435000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 526070000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 37622000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 55131000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 190728000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 782818000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 87910000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 257000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Payables: 778996000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Pretax Income: -186372000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2849980000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 13253000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 31810500.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: -1661000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 6814946000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 6447077000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -13471804.92
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Tax Provision: -31979000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.17
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 83340000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 10080103000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 6814946000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 51486000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 8762590000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 3252669000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1317513000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 8422467000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 538517000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 54166000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: -78513000.00
HEALTHX.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -78513000.00
HEALTHX.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 878640000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 430512000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 3415173000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 32277143.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.35
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 3152138000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 21685000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 21685000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 32277143.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.35
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 11297000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — EBIT: 10883000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — EBITDA: 32568000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 263035000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 1696000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1696000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 7610000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Net Income: 11297000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 11297000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 3687000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 11297000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 11297000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 3687000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -1696000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1696000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -9629000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -18240900.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Operating Income: -167477000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 3415173000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 136163000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 191669000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 9187000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 3152138000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 21685000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 12659100.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 5500000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 3582650000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 42197000.00
HEALTHX.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 42197000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — +Operating Expense: 1695827000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 503213000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — +Total Revenue: 13076521000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 3783638000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 860208000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 860208000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 76558000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 76558000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 1198000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 1198000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 5433663000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 5433663000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 31827066.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Basic EPS: -3.51
HEALTHX.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 124215000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -149315000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 35633000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 35633000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 318105000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 318105000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 301907000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 301907000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 302164000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 302164000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -343507000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -124298000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 68572000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Change In Payable: 281434000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 13649000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -108205000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 177692000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Common Stock: 318105000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 318105000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 6408881000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6408881000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 11984000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 11984000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 12084029000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3505950000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Current Assets: 2025488000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 2025488000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 912421000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 912421000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Depreciation: 66029000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 66029000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 66029000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 19408000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 66029000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 19408000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 31827066.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: -3.51
HEALTHX.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 11759000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -111713000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 17527000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — EBIT: -15759000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — EBIT: -143375000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — EBITDA: 50270000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — EBITDA: -123967000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — End Cash Position: 301907000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -795892000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -887613000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -510205000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of Business: 1121000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 4677000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Goodwill: 361434000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 361434000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 362446000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 362446000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 793706000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 793706000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Gross Profit: 992492000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 277688000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Interest Expense: 7817000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 4882000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 7817000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 4882000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -6256000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 112554000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Inventory: 1446450000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1446450000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 6629813000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 6629813000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 1711882000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 22156000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 22156000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 5433663000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 5433663000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 35633000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 35633000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 220932000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 220932000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 256565000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 256565000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 85659000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 85659000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 1243836000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 1243836000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Minority Interests: 26232000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 17975000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 100000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Net Income: 11759000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Net Income: -111713000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 11759000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -111713000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -14473000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -129688000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 11759000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -111713000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 11759000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -111713000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -23576000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -14473000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -129688000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Net Interest Income: -7817000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -4882000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 1729797000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 220932000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 220932000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -7817000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -4882000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -1000000000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Net PPE: 793706000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 793706000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -148096000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 6046435000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 6046435000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 137210000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 137210000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 54260000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 54260000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: -54598000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -68276000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Normalized Income: -52618102.31
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Normalized Income: -62997226.66
HEALTHX.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -738298000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Operating Income: -703335000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Operating Income: -225525000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Operating Revenue: 13076521000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 3783638000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 31810500.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 31810500.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 6090776000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 6090776000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 1012000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1012000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -159271000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 583018000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 583018000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 95391000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 95391000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 582708000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 137596000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 790148000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 233430000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Other Properties: 781722000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 781722000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 94570000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 94570000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 257000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 257000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Payables: 912421000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Payables: 912421000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 25863000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Pretax Income: -23576000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Pretax Income: -148257000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -222000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -7035529000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -149315000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 12084029000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3505950000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 66029000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 19408000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Sale Of Business: 100000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 8765326000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 1219000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Share Issued: 31810500.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 31810500.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Special Income Charges: -11270000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -9609000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 6408881000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 6408881000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 6046435000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 6046435000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 40490897.69
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -6975226.66
HEALTHX.NS income_statement (annual, 2026-03-31) — Tax Provision: -9103000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -18569000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.39
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.13
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 104548000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 104548000.00
HEALTHX.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -43353000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Total Assets: 9357687000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 9357687000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 6629813000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 6629813000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Total Debt: 256565000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 256565000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 7652717000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 7652717000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Total Expenses: 13779856000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 4009163000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 1704970000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1704970000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 7332199000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 7332199000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 792549000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 792549000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 52213000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 52213000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 104868000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -55691000.00
HEALTHX.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 104868000.00
HEALTHX.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -55691000.00
HEALTHX.NS balance_sheet (annual, 2026-03-31) — Working Capital: 1113067000.00
HEALTHX.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1113067000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — +Operating Expense: 166735000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — +Total Revenue: 437248000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 171993000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 290544000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -27990000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 0.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 18642000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 10138160.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Basic EPS: 0.51
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 40709000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 19939000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -846000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 101482000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 760000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 760000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 760000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -7428000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: -2902000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 2223000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Change In Payable: -69049000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Change In Receivables: 14325000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: -62831000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Changes In Cash: -13485000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Common Stock: 101482000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: 0.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 293663000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 0.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 246472000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Current Assets: 760176000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Current Debt: 128706000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 128706000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 0.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 300699000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Depreciation: 2350000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 2350000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 2350000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 2350000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 10138160.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Diluted EPS: 0.51
HECPROJECT.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 5145000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — EBIT: 15780000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — EBITDA: 18130000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — End Cash Position: 27224000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: 19486000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 155827000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: -36397000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -61000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 41347000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 0.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 48224000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Gross Profit: 190776000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Interest Expense: 10202000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 10202000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Interest Income: 2895000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 2895000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -25967000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Inventory: 155827000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 645002000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: 2580000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 18642000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 37969000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 222633000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 222633000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 37969000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 28285000.00
HECPROJECT.NS balance_sheet (annual, 2022-03-31) — Net Debt: 350579000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Net Income: 5145000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 5145000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 5145000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 5145000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 5145000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 5578000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 5145000.00
HECPROJECT.NS income_statement (annual, 2022-03-31) — Net Interest Income: -23073000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 37969000.00
HECPROJECT.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 37969000.00